During the past decade, Urologie im Schlosscarree conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urologie im Schlosscarree" #1 collaborator was "Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Urologie im Schlosscarree" are "Carcinoma, Renal Cell" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Urologie im Schlosscarree" in a lesser frequency.

The vast majority of trials in "Urologie im Schlosscarree" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Urologie im Schlosscarree". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urologie im Schlosscarree, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urologie im Schlosscarree, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".